"Compound ""Leualacin"", its preparation and its use in the treatment of cardiovascular disorders"
US5112807A · kind A · utility
9Cited by
1References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 5, 1989 |
| Grant date | May 12, 1992 |
| Priority date | — |
| Expiry date | Sep 5, 2009 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/80
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
A new compound, which we have named "Leualacin" has the formula (I): ##STR1## and may be prepared by cultivation of a microorganism of the genus Hapsidospora, especially Hapsidospora irregularis. The compound may be used for the treatment and prophylaxis of cardiovascular diseases and disorders, especially hypertension.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.